Clinical Trial Update: Treatment of Oral Premalignant Lesions With 5-ALA PDT [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 1/2 clinical trial evaluating 5-ALA photodynamic therapy for oral premalignant lesions. The conditions studied ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythroplakia
• Leukoplakia

Drugs mentioned

• 5-ALA PDT (5-aminolevulinic acid) for photodynamic therapy (5-aminolevulinic acid)

Snippet

Sponsor: University of Arkansas | Conditions: Leukoplakia, Erythroplakia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-11-13